YIV-906 (Formerly PHY906/KD018) With Sorafenib in HBV(+) Hepatocellular Carcinoma (HCC)
Phase 2 Completed
62 enrolled
OUTREACH2
Phase 2 Completed
8 enrolled
At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions
Completed
17,667 enrolled
Cell-free DNA From Junction of Hepatitis B Virus Integration in HCC Patients for Monitoring Post-resection Recurrence
Completed
207 enrolled
Immunogenicity and Safety of a Commercially Available Vaccine Co-administered With GSK HPV Vaccine (580299)
Phase 3 Completed
152 enrolled 21 charts
Modified Process Hepatitis B Vaccine in Healthy Neonates (V232-056)
Phase 2 Completed
566 enrolled